First-in-Central-Europe implantation of the self-expandable Pulsta valve in pulmonary position: Short-term results
In the study group, the Pulsta® valve provided good early-term effectiveness and feasibility without adverse events, and the overall mortality rate was 0%, highlighting the potential benefits of this intervention as measured by echocardiographic parameters.
Authors
- Grażyna Brzezińska‐Rajszys (ORCID: https://orcid.org/0000-0002-4958-4276)
- Sara Korabiewska-Pluta (ORCID: https://orcid.org/0000-0002-5208-1792)
- Mário Carminati (ORCID: https://orcid.org/0000-0001-9734-3007)
- Adam Koleśnik (ORCID: https://orcid.org/0009-0008-9630-8291)
- Monika Łubisz (ORCID: https://orcid.org/0000-0003-0930-3692)
- Tomasz Moszura (ORCID: https://orcid.org/0000-0003-3876-2791)
- Krzysztof W. Michalak (ORCID: https://orcid.org/0000-0001-9156-6648)
- Joanna Młodawska
Institutions
- IRCCS Policlinico San Donato (IT)
- Children's Memorial Health Institute (PL)
- Polish Mother’s Memorial Hospital Research Institute (PL)
Publication Details
- Journal
- Kardiologia Polska
- Published
- 2024-11-06
- DOI
- https://doi.org/10.33963/v.phj.103312
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42